vs
Bioceres Crop Solutions Corp.（BIOX）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
Bioceres Crop Solutions Corp.的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.1倍（$77.6M vs $70.9M），RCI HOSPITALITY HOLDINGS, INC.净利率更高（-7.8% vs -9.6%，领先1.8%），RCI HOSPITALITY HOLDINGS, INC.同比增速更快（-3.1% vs -16.8%），过去两年RCI HOSPITALITY HOLDINGS, INC.的营收复合增速更高（-2.0% vs -8.4%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
BIOX vs RICK — 直观对比
营收规模更大
BIOX
是对方的1.1倍
$70.9M
营收增速更快
RICK
高出13.7%
-16.8%
净利率更高
RICK
高出1.8%
-9.6%
两年增速更快
RICK
近两年复合增速
-8.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $70.9M |
| 净利润 | $-7.4M | $-5.5M |
| 毛利率 | 46.8% | — |
| 营业利润率 | 9.3% | -0.7% |
| 净利率 | -9.6% | -7.8% |
| 营收同比 | -16.8% | -3.1% |
| 净利润同比 | -20.2% | -2354.9% |
| 每股收益（稀释后） | $-0.12 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXRICK
| Q3 25 | $77.6M | $70.9M | ||
| Q2 25 | — | $71.1M | ||
| Q1 25 | $60.6M | $65.9M | ||
| Q4 24 | $98.8M | $71.5M | ||
| Q3 24 | $93.3M | $73.2M | ||
| Q2 24 | — | $76.2M | ||
| Q1 24 | $84.0M | $72.3M | ||
| Q4 23 | $140.2M | $73.9M |
净利润BIOXRICK
| Q3 25 | $-7.4M | $-5.5M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | $-1.6M | $3.2M | ||
| Q4 24 | $605.2K | $9.0M | ||
| Q3 24 | $-6.2M | $244.0K | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | $9.8M | $774.0K | ||
| Q4 23 | $1.2M | $7.2M |
毛利率BIOXRICK
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 50.8% | — | ||
| Q4 23 | 36.7% | — |
营业利润率BIOXRICK
| Q3 25 | 9.3% | -0.7% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | 1.5% | 12.4% | ||
| Q4 24 | 14.5% | 19.5% | ||
| Q3 24 | 2.5% | 4.8% | ||
| Q2 24 | — | -3.3% | ||
| Q1 24 | 15.7% | 6.4% | ||
| Q4 23 | 12.0% | 17.8% |
净利率BIOXRICK
| Q3 25 | -9.6% | -7.8% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | -2.6% | 4.9% | ||
| Q4 24 | 0.6% | 12.6% | ||
| Q3 24 | -6.6% | 0.3% | ||
| Q2 24 | — | -6.9% | ||
| Q1 24 | 11.6% | 1.1% | ||
| Q4 23 | 0.9% | 9.8% |
每股收益（稀释后）BIOXRICK
| Q3 25 | $-0.12 | $-0.60 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | $-0.02 | $0.36 | ||
| Q4 24 | $0.00 | $1.01 | ||
| Q3 24 | $-0.10 | $0.04 | ||
| Q2 24 | — | $-0.56 | ||
| Q1 24 | $0.14 | $0.08 | ||
| Q4 23 | $0.00 | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $288.3M | $261.1M |
| 总资产 | $734.9M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资BIOXRICK
| Q3 25 | $15.5M | $33.7M | ||
| Q2 25 | — | $29.3M | ||
| Q1 25 | $38.5M | $32.7M | ||
| Q4 24 | $29.2M | $34.7M | ||
| Q3 24 | $32.3M | $32.4M | ||
| Q2 24 | — | $34.9M | ||
| Q1 24 | $16.4M | $20.0M | ||
| Q4 23 | $24.4M | $21.2M |
总债务BIOXRICK
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
股东权益BIOXRICK
| Q3 25 | $288.3M | $261.1M | ||
| Q2 25 | — | $269.5M | ||
| Q1 25 | $345.0M | $268.8M | ||
| Q4 24 | $346.3M | $269.0M | ||
| Q3 24 | $346.0M | $263.4M | ||
| Q2 24 | — | $271.2M | ||
| Q1 24 | $348.5M | $285.8M | ||
| Q4 23 | $335.3M | $286.6M |
总资产BIOXRICK
| Q3 25 | $734.9M | $596.9M | ||
| Q2 25 | — | $597.4M | ||
| Q1 25 | $798.2M | $589.8M | ||
| Q4 24 | $835.2M | $586.2M | ||
| Q3 24 | $827.3M | $584.4M | ||
| Q2 24 | — | $601.0M | ||
| Q1 24 | $836.1M | $609.9M | ||
| Q4 23 | $819.5M | $619.2M |
负债/权益比BIOXRICK
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | — | $11.5M |
| 自由现金流率自由现金流/营收 | — | 16.2% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $34.9M |
8季度趋势，按日历期对齐
经营现金流BIOXRICK
| Q3 25 | $14.4M | $13.7M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | $23.3M | $8.5M | ||
| Q4 24 | $-5.4M | $13.3M | ||
| Q3 24 | $5.2M | $15.7M | ||
| Q2 24 | — | $15.8M | ||
| Q1 24 | $-17.4M | $10.8M | ||
| Q4 23 | $21.1M | $13.6M |
自由现金流BIOXRICK
| Q3 25 | — | $11.5M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $5.7M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $3.2M | ||
| Q4 23 | — | $8.5M |
自由现金流率BIOXRICK
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 14.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 4.4% | ||
| Q4 23 | — | 11.5% |
资本支出强度BIOXRICK
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 7.3% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 10.6% | ||
| Q4 23 | — | 6.9% |
现金转化率BIOXRICK
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | -8.85× | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | 14.00× | ||
| Q4 23 | 17.05× | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIOX
暂无分部数据
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
